Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3.5 years post-intervention: a follow-up of a randomized controlled high-impact trial

S Kontulainen; A Heinonen; P Kannus; M Pasanen; H Sievänen; I Vuori

Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3.5 years post-intervention: a follow-up of a randomized controlled high-impact trial

S Kontulainen
, A Heinonen
, P Kannus
, M Pasanen
, H Sievänen
, I Vuori

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

48 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	248-251
Julkaisu	Osteoporosis International
Vuosikerta	15
Tila	Julkaistu - 2004
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Siteeraa tätä

@article{13a3daa65da3455db5b1e94742b745bc,

title = "Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3.5 years post-intervention: a follow-up of a randomized controlled high-impact trial",

author = "S Kontulainen and A Heinonen and P Kannus and M Pasanen and H Siev{\"a}nen and I Vuori",

year = "2004",

language = "English",

volume = "15",

pages = "248--251",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer",

}

Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3.5 years post-intervention: a follow-up of a randomized controlled high-impact trial. / Kontulainen, S; Heinonen, A; Kannus, P et al.
julkaisussa: Osteoporosis International, Vuosikerta 15, 2004, s. 248-251.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3.5 years post-intervention: a follow-up of a randomized controlled high-impact trial

AU - Kontulainen, S

AU - Heinonen, A

AU - Kannus, P

AU - Pasanen, M

AU - Sievänen, H

AU - Vuori, I

PY - 2004

Y1 - 2004

M3 - Article

SN - 0937-941X

VL - 15

SP - 248

EP - 251

JO - Osteoporosis International

JF - Osteoporosis International

ER -